Showing 1331-1340 of 20413 results for "".
Expanding the Role of Hormonal Therapy and Isotretinoin in Acne Care
https://reachmd.com/programs/clinicians-roundtable/hormonal-isotretinoin-acne-care/49089/Explore when and how hormonal therapy and isotretinoin can optimize acne outcomes with Dr. John Barbieri. Challenging outdated assumptions, Dr. Barbieri advocates for broader use of hormonal therapies like spironolactone, clascoterone, and oral contraceptives beyond the traditional subset of adult wNegative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
https://reachmd.com/programs/frontlines-schizophrenia/negative-symptoms-schizophrenia-hidden-burden/36639/While positive symptoms of schizophrenia often take center stage, negative symptoms, such as apathy, anhedonia, and social withdrawal, can be just as disabling. That’s why Dr. Brian McDonough speaks with Dr. Ahmed Makhlouf about the clinical impact of negative symptoms and the tools and therapies thUnderstanding Schizophrenia: The Role of Neurotransmission and Inflammation
https://reachmd.com/programs/neurofrontiers/understanding-schizophrenia-the-role-of-neurotransmission-and-inflammation/36637/Our understanding of schizophrenia’s pathophysiology continues to evolve, highlighting the complex interplay between neurotransmitter dysregulation, inflammation, and progressive gray matter loss. Learn more with Dr. Jeffrey Lieberman, the Constance and Stephen Lieber Professor of Psychiatry at ColuDiagnosing and Treating Hemochromatosis: Expert Insights
https://reachmd.com/programs/gi-insights/diagnosing-and-treating-hemochromatosis-expert-insights/39214/Hemochromatosis, a genetic condition that causes the body to absorb too much iron from food, often goes unrecognized despite its prevalance. With unique diagnostic and management challenges, it's crucial to understand how it presents, which testing strategies are most effective, and what treatment oManaging Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
https://reachmd.com/programs/heart-matters/managing-statin-intolerance-practical-approaches-and-emerging-non-statin-options/37858/Statin intolerance, though uncommon, presents a challenge for patients who experience persistent side effects despite adjustments in dosing or switching statins. Dr. Matthew Sorrentino reviews evidence-baesd alternatives, shares insights on practical use in clinical care, and highlights the latest aTreatment Revolution in IgA Nephropathy
https://reachmd.com/programs/kdigo-conversations-nephrology/treatment-revolution-in-iga-nephropathy/37116/Treatment Revolution in IgA NephropathyDiagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively
https://reachmd.com/programs/gi-insights/diagnosing-and-treating-immune-checkpoint-inhibitor-colitis-effectively/32873/Immune checkpoint inhibitor (ICI) colitis comes with unique diagnostic and treatment challenges, which means that recognizing and managing it effectively is key to the best outcomes. Joining Dr. Peter Buch to share her insights on caring for patients with this complex condition is Dr. Yinghong Wang.Exploring Technological Advances in GI Training: Practical Insights for Clinicians
https://reachmd.com/programs/gi-insights/exploring-technological-advances-in-gi-training-practical-insights-for-clinicians/32875/Artificial intelligence, simulation platforms, augmented reality, and other technological innovations are transforming our approach to GI training. In this expert-led discussion, Dr. Peter Buch sits down with Dr. Nabil Mansour to discuss how we can integrate cutting-edge tools into colonoscopy trainDermwireTV: DermaRite Issues Recall for Several Hand Soaps
https://reachmd.com/videos/dermwire-tv/dermwiretv-dermarite-issues-recall-for-several-hand-soaps/37113/In this episode, new research shows switching between interclass biologics may be safe and effective for psoriasis patients; DermaRite recalls 4 skin care products over contamination concerns; and awareness grows for generalized pustular psoriasis through a new global awareness campaign.Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
https://reachmd.com/programs/project-oncology/are-subcutaneous-immunotherapies-expanding-access-and-efficiency-in-cancer-care/36401/Subcutaneous immunotherapies are emerging as a promising alternative to traditional IV delivery for immune checkpoint inhibitors, demonstrating comparable safety and efficacy along with meaningful time savings. But reimbursement gaps, dosing complexities, and biosimilar competition present challenge